TC
VIRX

TFS Capital’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

TFS Capital’s Portfolio VIRX Stock Details VIRX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
2017
Q1 		$158K Buy
2016
Q2 		– Sell
2016
Q1 		$14K Sell
2015
Q4 		$45K Sell
2015
Q3 		$187K Buy
2014
Q3 		– Sell
2014
Q2 		$396K Sell
2014
Q1 		$887K Buy